NSEGeneral Updates3d ago · 18 Sept 2026, 07:51 pm
General Updates
Piramal Pharma Limited · PPLPHARMA
✦ AI SummaryESG
Piramal Pharma Limited has been assigned an ESG rating of 67.1 (ESG Band: Leader) by Niche Ninety Nine Capability and Certifications (OPC) Private Limited, based on publicly available information.
Analysis Scores
Earnings Impact1/10
Growth Catalyst1/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact1/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Disclosure under Regulation 30 of Securities and Exchange Board of India(Listing Obligations and Disclosure Requirements) Regulations, 2015 ESG Rating
Attachments (1)
📄pdf
Download →
PIRAMALPHARMA_18092026194214_SEIntimation.pdf
View document text
Date: 18th September, 2026
BSE Limited National Stock Exchange of India Limited
P. J. Towers, Dalal Street, Fort, Exchange Plaza, Bandra-Kurla
Complex, Mumbai- 400 001 Bandra (East), Mumbai - 400 051
BSE scrip code: 543635 NSE Symbol: PPLPHARMA
Sub: Disclosure under Regulation 30 of Securities and Exchange Board of India
(Listing Obligations and Disclosure Requirements) Regulations, 2015
(‘SEBI Listing Regulations’) – ESG Rating
Dear Sir / Madam,
With reference to the captioned subject, we wish to inform you that as per the mail
received by the Company from BSE Limited on September 17, 2026, Niche Ninety
Nine Capability and Certifications (OPC) Private Limited (“Niche99”), has assigned
an Environment, Social and Governance (‘ESG’) Rating of ‘67.1’ (ESG Band:
Leader) to the Company.
Please note that the Company has not engaged Niche99 for the aforesaid ESG Rating.
Niche99 has independently prepared the report based on information available in
public domain.
Kindly treat this intimation for your information and record.
Thank you.
Yours truly,
For Piramal Pharma Limited
Maneesh Sharma
Company Secretary & Compliance Officer
Piramal Pharma Limited
CIN: L24297MH2020PLC338592
Registered Office: Ananta Building, Piramal Corporate Park, Opp. Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai – 400070, Maharashtra, India
Tel No. +91 22 3802 3000 / 4000; Email Id: shareholders.ppl@piramal.com
www.piramalpharma.com